Health behaviors and advanced planning in cognitively unimpaired older adults following amyloid PET disclosure: Preliminary findings from the Wisconsin Registry for Alzheimer’s Prevention

As biomarker testing becomes more widely available, people will have opportunities to learn their Alzheimer’s disease (AD) biomarker results. We developed an AD biomarker disclosure protocol to return results to research participants interested in learning this risk‐related information (Figure 1). This analysis assesses the effectiveness of a post‐disclosure dementia risk‐reduction counseling session and investigates health and advanced planning behaviors following amyloid PET disclosure.